Regeneron Pharmaceuticals (REGN) has solidified its position as a leader in the biotech sector, thanks to its innovative therapies and consistent revenue growth. In this post, we’ll break down the company’s financial performance, its current stock valuation, and provide insights on whether REGN presents an attractive investment opportunity today. 1. Revenue StructureRegeneron’s revenue primarily..
